ESTA
Undervalued by 62% based on the discounted cash flow analysis.
Market cap | $965.25 Million |
---|---|
Enterprise Value | $879.11 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $-3.03 |
Beta | 0.78 |
Outstanding Shares | 28,942,937 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -11.42 |
---|---|
PEG | 26.56 |
Price to Sales | 6.96 |
Price to Book Ratio | 34.8 |
Enterprise Value to Revenue | 5.74 |
Enterprise Value to EBIT | -15.11 |
Enterprise Value to Net Income | -13 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0.08 |
No data
No data
Establishment Labs Holdings Inc. is a global medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfoli...